Technique and Results of Regional Hyperthermic Cytostatic Arm Perfusion for Malignant Melanoma

Overview

Journal Surg Today

Specialty General Surgery

Date 1997 Jan 1

PMID 9306586

Authors

P Wurl

U Eichfeld

H D Pauer

A Glaser

U Rose

H Dralle

Affiliations

Soon will be listed here.

Abstract

Isolated hyperthermic cytostatic limb perfusion has been established as an efficient procedure for the treatment of malignant melanoma of the limbs. However, perfusions of the upper extremities are generally carried out much less frequently than would be expected given the distribution pattern of malignant melanoma and sarcoma. Thus, isolated descriptions of treatment results for perfusion of the upper extremities are not available. Between 1991 and 1994, arm perfusions using melphalan 1.0 mg/kg body weight were given to 14 patients with malignant melanoma, using the standardized method of perfusion described herein. Within an average observation period of 34.9 months (range, 12-65 months), 11 (78.7%) of the 14 patients who had M.D. Anderson stage II-IV melanoma remained free of local recurrence. In fact, 10 (71.6%) of the patients were still alive at the end of the observation period. None of the 14 patients showed any systemic adverse effects, although 1 patient developed a lymphedema 32 months after perfusion and 2 patients showed a postoperative temporary neurologic deficit. These results demonstrate that isolated perfusion of the upper limb with heat and melphalan under standardized conditions remains the treatment of choice for melanoma of the arm, as for melanoma of the leg, without a higher rate of complications.

References

Janoff K, Moseson D, NOHLGREN J, Davenport C, Richards C, FLETCHER W . The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg. 1982; 196(3):316-23. PMC: 1352606. DOI: 10.1097/00000658-198209000-00010. View

Bryant P, Balderson G, Mead P, Egerton W . Hyperthermic isolated limb perfusion for malignant melanoma: response and survival. World J Surg. 1995; 19(3):363-8. DOI: 10.1007/BF00299159. View

Cumberlin R, De Moss E, Lassus M, Friedman M . Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol. 1985; 3(7):1022-31. DOI: 10.1200/JCO.1985.3.7.1022. View

Kroon B . Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. Eur J Surg Oncol. 1988; 14(2):101-10. View

Veronesi U, Adamus J, BANDIERA D, Brennhovd O, Caceres E, Cascinelli N . Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982; 49(11):2420-30. DOI: 10.1002/1097-0142(19820601)49:11<2420::aid-cncr2820491133>3.0.co;2-2. View

Krementz E . Lucy Wortham James lecture. Regional perfusion. Current sophistication, what next?. Cancer. 1986; 57(3):416-32. DOI: 10.1002/1097-0142(19860201)57:3<416::aid-cncr2820570304>3.0.co;2-m. View

STEHLIN J, GIOVANELLA B, De Ipolyi P, Muenz L, Anderson R . Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet. 1975; 140(3):339-48. View

Vaglini M, Belli F, Ammatuna M, Inglese M, Manzi R, Prada A . Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer. 1994; 73(2):483-92. DOI: 10.1002/1097-0142(19940115)73:2<483::aid-cncr2820730238>3.0.co;2-s. View

Nagel K, Junginger T . [Perfusion of the extremities in malignant melanoma. Indication, technic and results]. Dtsch Med Wochenschr. 1987; 112(42):1626-9. DOI: 10.1055/s-2008-1068304. View

10.

Krementz E, Carter R, Sutherland C, Campbell M . The use of regional chemotherapy in the management of malignant melanoma. World J Surg. 1979; 3(3):289-304. DOI: 10.1007/BF01556579. View

11.

Rauschecker H, Foth H, Michaelis H, Horst F, Gatzemeier W, Willenbrock C . Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb. Cancer Chemother Pharmacol. 1991; 27(5):379-84. DOI: 10.1007/BF00688861. View

12.

Martijn H, Oldhoff J, Schraffordt Koops H . Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs. Eur J Cancer (1965). 1981; 17(4):471-6. DOI: 10.1016/0014-2964(81)90257-7. View

13.

Cavaliere R, Ciocatto E, GIOVANELLA B, HEIDELBERGER C, JOHNSON R, MARGOTTINI M . Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967; 20(9):1351-81. DOI: 10.1002/1097-0142(196709)20:9<1351::aid-cncr2820200902>3.0.co;2-#. View

14.

Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P . [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities]. Langenbecks Arch Chir. 1990; 375(4):208-13. DOI: 10.1007/BF00187440. View

15.

Eichfeld U, Glaser A, Schneider G, Kraus J, Pauer H, Schwarz I . [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results]. Zentralbl Chir. 1993; 118(2):63-8. View

16.

Oleson J, Calderwood S, Coughlin C, Dewhirst M, Gerweck L, Gibbs Jr F . Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol. 1988; 11(3):368-80. DOI: 10.1097/00000421-198806000-00013. View

17.

Krauss J, Lange U, Pauer H, Krauss I . [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities]. Z Exp Chir Transplant Kunstliche Organe. 1984; 17(5):269-74. View

18.

Hoekstra H, Schraffordt Koops H, de Vries L, van Weerden T, Oldhoff J . Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer. 1993; 72(4):1224-9. DOI: 10.1002/1097-0142(19930815)72:4<1224::aid-cncr2820720415>3.0.co;2-b. View

19.

Ghussen F, Kruger I, GROTH W, Stutzer H . The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer. 1988; 61(4):654-9. DOI: 10.1002/1097-0142(19880215)61:4<654::aid-cncr2820610406>3.0.co;2-v. View

20.

Lejeune F, Lienard D, el Douaihy M, Seyedi J, Ewalenko P . Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol. 1989; 15(6):510-9. View